CN Patent

CN102026671B — 整联蛋白靶向试剂及使用其的体内和体外成像方法

Assigned to Merck Sharp and Dohme LLC · Expires 2014-09-03 · 12y expired

What this patent protects

本发明提供靶向整联蛋白的试剂的一个家族，它可以用作成像试剂和/或治疗性试剂。这些试剂可以用于成像在受试者中的血管发生、炎症或其他生理学过程。

USPTO Abstract

本发明提供靶向整联蛋白的试剂的一个家族，它可以用作成像试剂和/或治疗性试剂。这些试剂可以用于成像在受试者中的血管发生、炎症或其他生理学过程。

Drugs covered by this patent

pafolacianine-sodium (PAFOLACIANINE SODIUM)

Patent Metadata

Patent number: CN102026671B
Jurisdiction: CN
Classification: —
Expires: 2014-09-03
Drug substance claim: No
Drug product claim: No
Assignee: Merck Sharp and Dohme LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.